Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 18,000 shares, a decline of 43.4% from the January 15th total of 31,800 shares. Based on an average trading volume of 1,799,300 shares, the short-interest ratio is presently 0.0 days.
Vivos Price Performance
OTCMKTS:RDGL traded up $0.01 during trading hours on Monday, hitting $0.16. The company had a trading volume of 1,977,800 shares, compared to its average volume of 952,733. The company has a market capitalization of $70.14 million, a PE ratio of -15.91 and a beta of 0.89. The stock has a 50-day moving average price of $0.12 and a 200 day moving average price of $0.13. Vivos has a 52 week low of $0.05 and a 52 week high of $0.26.
About Vivos
(
Get Free Report)
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
Further Reading
Before you consider Vivos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivos wasn't on the list.
While Vivos currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
